Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1296-2025

BD BBL TB Stain Kit K, Catalog (REF): 212522 Recall

BD BBL TB Stain Kit K, Catalog (REF): 212522

FDA recall Class II

Ongoing

FDA lists this Class II recall for BD BBL TB Stain Kit K, Catalog (REF): 212522. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1296-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 12, 2025
FDA report date
Mar 12, 2025
Quantity in commerce
247 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BD BBL TB Stain Kit K, Catalog (REF): 212522

Affected model & UDI checker

Search the exact identifiers published for Z-1296-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedBD BBL TB Stain Kit K, Catalog (REF): 212522Check source notice00382902125228
FDA code information

Catalog (REF): 212522; UDI-DI: 00382902125228; Expiration Date: 2025/04/30; Date of Manufacture: 07/10/2024; Lot Number: 4191205;

View the original FDA recall notice

Why was this product recalled?

One component of the kit was shipped with an expiration date of 30Sep2024 while the Certificate of Analysis (COA) indicated an expiration date of 30Apr2025.

What actions did Becton Dickinson & Co. take?

On February 12, 2025 URGENT: MEDICAL DEVICE PRODUCT REMOVAL letters were sent to distributors. Please Take the Following Actions: 1. Immediately inspect your inventory for the specific catalog and lot number listed to determine if the lot in your possession are impacted and immediately discard any remaining inventory of the affected product. 2. Ensure the contents of this notification are read and understood. 3. Identify all customers within your distribution network that purchased any affected product as defined in this Product Recall. Provide a copy of the attached customer letter to all customers who received the affected lots to advise them of this Product Recall on BD s behalf. 4. Complete the attached Distributor Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. BD is committed to advancing the world of health. Our primary objectives are patient and user safety and providing you with quality products. We apologize for any inconvenience this issue may have caused you and thank you in advance for helping us to resolve this matter as quickly and effectively as possible. On February 12, 2025 URGENT: MEDICAL DEVICE PRODUCT REMOVAL letters were sent to customers. Actions for Customers: 1) Immediately inspect your inventory for the specific catalog and lot number listed todetermine if the lot in your possession are impacted and immediately discard any remaining inventory of the affected product. 2) Ensure the contents of this notification are read and understood by those within yourorganization. 3) Share and post this customer letter with users of this application at your facility andforward to any customers to whom you may have distributed the product to ensureawareness. 4) Complete the attached Customer Response Form and return to the BD contactnoted on the form whether or not you have any of the impacted material so that BDmay acknowledge

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology